Meriwether Wealth & Planning’s IDEAYA Biosciences IDYA Stock Holding History

Meriwether Wealth & Planning’s Portfolio IDYA Stock Details IDYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.04K	Buy	+53	New	+$2K	﹤0.01%	649

Other funds holding IDYA

Congress Asset Management Boston, Massachusetts $15.4B AUM 30.39% 1-Year Est. Return

Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return

AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

Atria Investments Charlotte, North Carolina $10.3B AUM 19.62% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

SignatureFD Atlanta, Georgia $7.76B AUM 16.09% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Meriwether Wealth & Planning's IDYA Position: Q3 2026 in Review

Meriwether Wealth & Planning opened a new position in IDEAYA Biosciences (IDYA) in Q3 2026: 53 shares worth $2.04K. The stake represents ﹤0.01% of the portfolio and ranks #649 among its holdings.

30 funds tracked by Wall St. Rank hold IDYA as of Q3 2026.

Meriwether Wealth & Planning held 53 shares of IDEAYA Biosciences worth $2.04K as of Q3 2026.
IDEAYA Biosciences was a new Meriwether Wealth & Planning position in Q3 2026.
IDEAYA Biosciences made up ﹤0.01% of Meriwether Wealth & Planning's portfolio in Q3 2026, its #649 holding.
30 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q3 2026.

Based on Meriwether Wealth & Planning's 13F filing for Q3 2026, filed 13 Oct 2026.